Activation of phosphatidylinositol 3-kinase/Akt limits FGF-2-induced VEGF release in osteoblasts

Molecular and Cellular Endocrinology

Volumn 267, Issue 1-2, 2007, Pages 46-54

  Takai, Shinji ^a   Tokuda, Haruhiko ^a,b   Hanai, Yoshiteru ^a,b   Kozawa, Osamu ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

FGF 2; Osteoblast; PI3K Akt; VEGF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; FIBROBLAST GROWTH FACTOR 2; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; CELLS, CULTURED; CHROMONES; DACTINOMYCIN; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 2; FLAVONOIDS; GLYCOGEN SYNTHASE KINASE 3; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 1; MORPHOLINES; OSTEOBLASTS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33847245974     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.12.036     Document Type: Article

References (40)

1. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., and Saltiel A.R. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270 (1995) 27489-27494
2. Arcaro A., and Wymann M.P. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296 (1993) 297-301
3. Baylink D.J., Finkleman R.D., and Mohan S. Growth factor to stimulate bone formation. J. Bone Miner. Res. 8 (1993) S565-S572
4. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., and Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13681-13686
5. Bolander M.E. Regulation of fracture repair by growth factors stimulate tyrosine kinase activity in vivo. Proc. Soc. Exp. Biol. Med. 200 (1992) 165-170
6. Brighton C.T. structure and function of the growth plate. Clin. Orthop. Rel. Res. 136 (1978) 22-32
7. Brighton C.T., and Hunt R.M. Early histological and ultrastructural changes in medullary fracture callus. Am. J. Bone Joint Surg. 73 (1991) 832-847
8. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
9. Chan T.O., Rittenhouse S.E., and Tsichlis P.N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 68 (1999) 965-1014
10. Chaudhary L.R., and Hruska K.A. The cell survival signal Akt is differently activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells. J. Cell Biochem. 81 (2001) 304-311
11. Coffer P.J., Jin J., and Woodgett J.R. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335 (1998) 1-13
12. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
13. D'Amore P.A., Brown Jr. R.H., Ku P.T., Hoffman E.P., Watanabe H., Arahata K., Ishihara T., and Folkman J. Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann. Neurol. 35 (1994) 362-365
14. Debiais F., Lefevre G., Lemonnier J., Le Mee S., and Lasmoles F. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent-beta-catenin-independent signaling pathway. Exp. Cell Res. 297 (2004) 235-246
15. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., Segal R.A., Kaplan D.R., and Greenberg M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275 (1997) 661-665
16. Erlebacher A., Filvaroff E.H., Gitelman S.E., and Derynck R. Toward a molecular understanding of skeletal development. Cell 80 (1995) 371-378
17. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 18 (1997) 4-25
18. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., and Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5 (1999) 623-628
19. Goad D.L., Rubin J., Wang H., Tashijian Jr. A.H., and Patterson C. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I. Endocrinology 137 (1996) 2262-2268
20. Hu Y., Qiao L., Wang S., Rong S.B., Meuillet E.J., Berggren M., Gallegos A., Powis G., and Kozikowski A.P. 3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth. J. Med. Chem. 43 (2000) 3045-3051
21. Hurley M.M., Abreu C., Harrison J.R., Lichtler A.C., Raisz L.G., and Kream B.E. Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268 (1993) 5588-5593
22. Ii M., Yoshida H., Aramaki Y., Masuya H., Hada T., Hatanaka M., and Ichimori Y. Improved enzyme immunoassay for human basic fibroblast growth factor using a new enhanced chemiluminescence system. Biochem. Biophys. Res. Commun. 193 (1993) 540-545
23. Kato K., Ito H., Hasegawa K., Inaguma Y., Kozawa O., and Asano T. Modulation of the stress-induced synthesis of hsp27 and αB-crystallin by cyclic AMP in C6 glioma cells. J. Neurochem. 66 (1996) 946-950
24. Katso R., Okkenhaug K., Ahmadi K., White S., Timms J., and Waterfield M.D. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 17 (2001) 615-675
25. 2 in osteoblast-like cells. Exp. Cell Res. 198 (1992) 130-134
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
27. Marie P.J. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 316 (2003) 23-32
28. Noda T., Tokuda H., Yoshida M., Yasuda E., Hanai Y., and Kozawa O. Possible involvement of phosphatidylinositol 3-kinase/Akt pathway in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblasts. Horm. Metab. Res. 37 (2005) 270-274
29. Parfitt A.M. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J. Cell Biochem. 55 (1994) 273-286
30. Reich E. Biochemistry of actinomycins. Cancer Res. 23 (1963) 1428-1441
31. 3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocr. Res. 23 (1997) 213-229
32. Srivastava A.K., and Pandey S.K. Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin. Mol. Cell Biochem. 182 (1998) 135-141
33. Sudo H., Kodama H., Amagai Y., Yamamoto S., and Kasai S. In vivo differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol. 96 (1983) 191-198
34. Tokuda H., Kozawa O., and Uematsu T. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p44/p42 mitogen-activated protein kinase and p38 mitogen-activated protein kinase. J. Bone Miner. Res. 15 (2000) 2371-2379
35. Tokuda H., Hirade K., Wang X., Oiso Y., and Kozawa O. Involvement of SAPK/JNK in basic fibroblast growth factor-induced VEGF release in osteoblasts. J. Endocrinol. 177 (2003) 101-107
36. Vlahos C.J., Matter W.F., Hui K.Y., and Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269 (1994) 5721-5728
37. 3 in human osteoblast-like cells. J. Bone Miner. Res. 11 (1996) 472-479
38. Widmann C., Gibson S., Jarpe M.B., and Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79 (1999) 143-180
39. Yoshida M., Niwa M., Ishisaki A., Hirade K., Ito H., Shimizu K., Kato K., and Kozawa O. Methotrexate enhances prostaglandin D2-stimulated heat shock protein 27 induction in osteoblast. Prostaglandins Leukot. Essent. Fatty Acids 71 (2004) 351-362
40. Zelzer E., and Olsen B.R. Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr. Top. Dev. Biol. 65 (2005) 169-187